Calidi Biotherapeutics Inc (CLDI)
0.236
-0.01
(-4.88%)
USD |
NYAM |
May 21, 16:00
0.235
0.00 (0.00%)
After-Hours: 20:00
Calidi Biotherapeutics Cash from Financing (TTM): 21.69M for March 31, 2024
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
| Date | Value |
|---|---|
| March 31, 2024 | 21.69M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
21.69M
Minimum
Mar 2024
21.69M
Maximum
Mar 2024
21.69M
Average
21.69M
Median
Mar 2024
Cash from Financing (TTM) Benchmarks
| Minerva Neurosciences Inc | 19.60M |
| Viking Therapeutics Inc | 873.23M |
| CytomX Therapeutics Inc | 30.40M |
| Genprex Inc | 13.31M |
| Janux Therapeutics Inc | 380.14M |